Re: Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy

J Natl Cancer Inst. 2011 Feb 16;103(4):352-3. doi: 10.1093/jnci/djq528. Epub 2011 Jan 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anthracyclines / administration & dosage*
  • Antigens, Neoplasm / metabolism*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / metabolism*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology*
  • Chemotherapy, Adjuvant
  • Cyclophosphamide / administration & dosage
  • DNA Topoisomerases, Type II / metabolism*
  • DNA-Binding Proteins / metabolism*
  • Epirubicin / administration & dosage
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Methotrexate / administration & dosage
  • Predictive Value of Tests
  • Prognosis
  • Treatment Outcome

Substances

  • Anthracyclines
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • DNA-Binding Proteins
  • Epirubicin
  • Cyclophosphamide
  • DNA Topoisomerases, Type II
  • Fluorouracil
  • Methotrexate